✉news TechnologyTechnology first seen 1 d ago, last 1 d ago, peak #14
Pet cloning, cryonics and longevity drugs: biotech's new market
Original: Pet cloning, cryonics and longevity drugs: biotech’s new market
Biotech companies are increasingly selling radical services once confined to science fiction, including pet cloning, cryonics and experimental longevity drugs. The industry is turning these frontier technologies into a commercial market, raising questions about cost, ethics and who can afford them.
Why now: Growing interest in life-extension and cloning services is pushing biotech into a controversial new consumer market.
biotech industrypet cloning companiescryonics providerslongevity drug developers
Rank over time, top of the chart is #1. 6 snapshots from 1 d ago to 1 d ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/2735947